HealthCor Management’s Immunogen Inc IMGN Stock Holding History

HealthCor Management’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$744K	Sell	150,000 -1,150,000	-88%	-$6.24M	0.68%	19
2022 Q3	$6.21M	Buy	1,300,000 +800,000	+160%	+$4.22M	0.78%	37
2022 Q2	$2.25M	Sell	500,000 -810,340	-62%	-$3.52M	0.23%	48
2022 Q1	$6.24M	Hold	1,310,340	–	–	0.42%	42
2021 Q4	$9.72M	Buy	1,310,340 +1,110,340	+555%	+$6.9M	0.53%	42
2021 Q3	$1.13M	Buy	+200,000	New	+$1.16M	0.05%	68
2020 Q3	–	Sell	-1,200,000	Closed	-$5.52M	–	59
2020 Q2	$5.52M	Buy	+1,200,000	New	+$5.1M	0.23%	42

Other funds holding IMGN

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

HealthCor Management's IMGN Position: Q4 2022 in Review

HealthCor Management reduced its Immunogen Inc (IMGN) stake by 88% in Q4 2022, selling an estimated $6.24M and leaving 150,000 shares worth $744K. The position accounts for 0.68% of the portfolio, ranked #19.

HealthCor Management first reported a position in IMGN in Q2 2020 and has held it in 7 quarters since. The position peaked at $9.72M in Q4 2021. 204 funds tracked by Wall St. Rank hold IMGN as of Q4 2022.

HealthCor Management held 150,000 shares of Immunogen Inc worth $744K as of Q4 2022.
HealthCor Management sold 1,150,000 Immunogen Inc shares in Q4 2022, an estimated $6.24M.
Immunogen Inc made up 0.68% of HealthCor Management's portfolio in Q4 2022, its #19 holding.
HealthCor Management first reported a position in Immunogen Inc in Q2 2020 and has held it in 7 quarters since.
HealthCor Management's Immunogen Inc position peaked at $9.72M in Q4 2021.
204 funds tracked by Wall St. Rank held Immunogen Inc as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.